CDH2 and neoplasm: CLDNs, along with E- and N-cadherins and vimentin, are frequently dysregulated in cancer and are also known as potent regulators of EMT, tumor invasion, and tumor stemness, which are fundamental factors contributing to tumor resistance to chemotherapy.